AIP is a compact, validated marker of atherogenic dyslipidaemia — the lipid pattern most strongly linked to insulin resistance and small dense LDL formation.
AIP is a compact, validated marker of atherogenic dyslipidaemia — the lipid pattern most strongly linked to insulin resistance and small dense LDL formation. It improves measurably with diet, exercise, and weight loss within weeks, making it an excellent lifestyle-tracking marker.
Insulin resistance, metabolic syndrome, type 2 diabetes, obesity, inactivity, high refined-carbohydrate and saturated fat intake, hypothyroidism, genetic dyslipidaemias.
Asymptomatic. High AIP is a silent cardiovascular risk signal.
Omega-3 fatty acids, Mediterranean dietary pattern, aerobic exercise. Dual HDL-raising / TG-lowering interventions are most effective.
Refined carbohydrates and sugar. Alcohol. Trans fats create a double-negative effect (HDL down, small dense LDL up).
Educational information only — not a diagnosis. Every Pheno result is interpreted in context and reviewed by a physician.
See all 119 markers we test →